Menu
sharewise sharewise
Log in
Sign up
Log in
Sign up
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.
  1. Predictions
buy

Evofem Biosciences Inc. buy krebskrebs

Evofem Biosciences Inc.
Start price
€34.73
22.03.21 / 50%
Target price
€52.50
22.03.22
Performance (%)
-84.26%
End price
€5.47
23.03.22
Summary
This prediction ended on 23.03.22 with a price of €5.47. Massive losses of -84.26% were the result for the BUY prediction by krebskrebs. krebskrebs has 50% into this prediction
Performance without dividends (%)
Name 1w 1m 1y 3y
Evofem Biosciences Inc. - - - -
iShares Core DAX® 3,59 % 6,43 % 15,38 % 52,31 %
iShares Nasdaq 100 5,81 % 6,38 % 41,46 % 91,77 %
iShares Nikkei 225® 4,08 % 9,31 % 48,95 % 65,86 %
iShares S&P 500 4,14 % 4,94 % 31,59 % 65,33 %

Comments by krebskrebs for this prediction

In the thread Evofem Biosciences diskutieren
Prediction Buy
Perf. (%) -84.26%
Target price 3.500
Change
Ends at

Buy mit Kursziel 3,5

krebskrebs 
0
Report Share
22.03.21
In the thread Trading Evofem Biosciences
Prediction Buy
Perf. (%) -84.26%
Target price 3.500
Change
Ends at 22.03.22

Die von krebskrebs gewählte maximale Laufzeit wurde überschritten

krebskrebs 
0
Report Share
23.03.22